Evidence map›Paper›PMID 29599276›Full record

ArticleCirculation research2018

Immune Modulation as a Treatment for Abdominal Aortic Aneurysms.

S Keisin Wang, Michael P Murphy

Abstract read
In one paragraph

Article in Circulation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The mechanism and therapy of aortic aneurysms.Signal transduction and targeted therapy · 2023
    Review
  10. Increase of Vδ2Immune network · 2021
    Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S Keisin WangFrom the Division of Vascular Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis.
Michael P MurphyFrom the Division of Vascular Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis. mipmurph@iupui.edu.

Funding

Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial DiseaseUM1HL113457 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI MURPHY, MICHAEL PATRICK · 2012 to 2018
$3.0M
A Clinical and Histological Analysis of Mesenchymal Stem Cells in AmputationR01HL128827 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI MURPHY, MICHAEL PATRICK · 2016 to 2019
$1.8M
Mesenchymal stem cells induce regulatory T cells in patients with aortic aneurysmI01CX001407 · VA · RLR VA MEDICAL CENTER · PI MURPHY, MICHAEL PATRICK · 2017 to 2021
–
CSRD VA I01 CX001407NHLBI NIH HHS R01 HL128827NHLBI NIH HHS UM1 HL113457
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunomodulationAortic Aneurysm, AbdominalHumansangiotensin IIaortic aneurysm, abdominaldoxycyclinematrix metalloproteinasesrisk factors

Identifiers

PMID29599276
PMCPMC5880296

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.